[{"id":"80321407-2116-4248-84f6-3c84566bd252","acronym":"ACT","url":"https://clinicaltrials.gov/study/NCT05902520","created_at":"2023-06-15T18:08:41.365Z","updated_at":"2024-07-02T16:35:42.423Z","phase":"Phase 1","brief_title":"Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors","source_id_and_acronym":"NCT05902520 - ACT","lead_sponsor":"AgonOx, Inc.","biomarkers":" BRAF • CD8","pipe":"","alterations":" ","tags":["BRAF • CD8"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AGX-148"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 06/19/2023","start_date":" 06/19/2023","primary_txt":" Primary completion: 05/19/2025","primary_completion_date":" 05/19/2025","study_txt":" Completion: 05/19/2026","study_completion_date":" 05/19/2026","last_update_posted":"2023-07-20"}]